Log in to save to my catalogue

Development and validation of multivariate models integrating preoperative clinicopathological and r...

Development and validation of multivariate models integrating preoperative clinicopathological and r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd6dd0c6c0f04445a5d9bfb0852c3096

Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer

About this item

Full title

Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-08, Vol.12 (1), p.14177-11, Article 14177

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The combination of trastuzumab and chemotherapy is recommended as first-line therapy for patients with human epidermal growth factor receptor 2 (HER2) positive advanced gastric cancers (GCs). Successful trastuzumab-induced targeted therapy should be based on the assessment of HER2 overexpression. This study aimed to evaluate the feasibility of mult...

Alternative Titles

Full title

Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dd6dd0c6c0f04445a5d9bfb0852c3096

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd6dd0c6c0f04445a5d9bfb0852c3096

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-18433-z

How to access this item